Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany
Kulp W, Hemels M, Greiner W, von der Schulenburg J (2005)
In: Value in Health. Value in Health, 8(6). Blackwell: A210.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Kulp, W.;
Hemels, M.;
Greiner, WolfgangUniBi;
von der Schulenburg, J.
Einrichtung
Erscheinungsjahr
2005
Titel des Konferenzbandes
Value in Health
Serien- oder Zeitschriftentitel
Value in Health
Band
8
Ausgabe
6
Seite(n)
A210
ISSN
1098-3015
Page URI
https://pub.uni-bielefeld.de/record/1601562
Zitieren
Kulp W, Hemels M, Greiner W, von der Schulenburg J. Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. In: Value in Health. Value in Health. Vol 8. Blackwell; 2005: A210.
Kulp, W., Hemels, M., Greiner, W., & von der Schulenburg, J. (2005). Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health, Value in Health, 8, A210. Blackwell. https://doi.org/10.1016/S1098-3015(10)67792-3
Kulp, W., Hemels, M., Greiner, Wolfgang, and von der Schulenburg, J. 2005. “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”. In Value in Health, 8:A210. Value in Health. Blackwell.
Kulp, W., Hemels, M., Greiner, W., and von der Schulenburg, J. (2005). “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany” in Value in Health Value in Health, vol. 8, (Blackwell), A210.
Kulp, W., et al., 2005. Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. In Value in Health. Value in Health. no.8 Blackwell, pp. A210.
W. Kulp, et al., “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”, Value in Health, Value in Health, vol. 8, Blackwell, 2005, pp.A210.
Kulp, W., Hemels, M., Greiner, W., von der Schulenburg, J.: Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. Value in Health. Value in Health. 8, p. A210. Blackwell (2005).
Kulp, W., Hemels, M., Greiner, Wolfgang, and von der Schulenburg, J. “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”. Value in Health. Blackwell, 2005.Vol. 8. Value in Health. A210.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar